Exchange: NASDAQ
Industry: Pharmaceuticals & Biotechnology
Last Trade: 4:00 PM ET 5/24/2012
Last 10 Quotes:
What's This?
| Most Recent Quarter ($) | Same Quarter Last Year ($) | % Change | |
| EPS, Pro Forma | -0.61 | -0.24 | 152.05 |
| EPS, GAAP | -0.66 | -0.26 | -0.26 |
| Consensus Estimate | -0.30 | -0.23 | 31.44 |
| Trailing 12 Months | Year-Earlier Period | % Change | |
| EPS, Pro Forma | -1.55 | -0.98 | 57.96 |
| EPS, GAAP | -3.73 | -1.06 | 251.37 |
| Consensus Estimate | -0.62 | -1.22 | -49.48 |
| AMLN | Industry Average | |
| P/E (TTM) | 0.00 | NA |
| P/E (Forward) | 0.00 | NA |
| PEG Ratio | 0.00 | 2.17 |
| Price/Sales | 6.16 | 4.18 |
| Beta | 1.00 | 0.62 |
| 2:36 PM | 4/25/2012 | Icahn: Suit Against Amylin Dropped After Talks With CEO |
| 5/15/2012 | Tuesday’s biggest gaining and declining stocks (MarketWatch.com) |
| 5/15/2012 | Tuesday’s biggest gaining and declining stocks (MarketWatch.com) |
| 5/15/2012 | Tuesday’s biggest gaining and declining stocks (MarketWatch.com) |
| 5/15/2012 | Tuesday’s biggest gaining and declining stocks (MarketWatch.com) |
| 5/15/2012 | Tuesday’s biggest gaining and declining stocks (MarketWatch.com) |
| 5/15/2012 | Tuesday’s biggest gaining and declining stocks (MarketWatch.com) |
| 5/15/2012 | U.S. Retail Strength, German GDP Growth Sends Stocks Higher (Barrons.com) |
| 4/27/2012 | One Big Disbelief of an Amylin Buyout… Worth Only $12 Per Share? (AMLN, BMY, MRK, AZN, SNY, PFE, NVO) (24/7 Wall St) |
![[sm061210things]](http://s.wsj.net/public/resources/images/PF-AC562_sm0612_C_20120514113337.jpg)
![[sm0612wedding4]](http://s.wsj.net/public/resources/images/PF-AC579_sm0612_C_20120515172853.jpg)
![[sm0612strat]](http://s.wsj.net/public/resources/images/PF-AC580_sm0612_C_20120515180019.jpg)
![[sm0612roi]](http://s.wsj.net/public/resources/images/PF-AC573_sm0612_C_20120515125902.jpg)
